D
Viatris Inc. VTRS
$10.42 $0.070.63% NASDAQ
Recommendation
Prev Close
$10.35
Volume
3,873,668
Avg Vol (90D)
9,358,311
Market Cap
$12.07B
Dividend & Yield
$0.48(4.64%)
52-Week Range
$6.85 - $13.55
P/E (TTM)
--
EPS (TTM)
-$2.91
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Viatris Inc. (VTRS) Updates Bylaws and Announces 2026 Annual Meeting Date
10/26/2025 - GuruFocus
Viatris Announces Approval of Amended Bylaws
10/24/2025 - TipRanks Financial Blog
3 Volatile Stocks with Warning Signs
10/24/2025 - StockStory Articles
Viatris (VTRS): Assessing Valuation After Recent Share Price Gains and Recovery Signs
10/23/2025 - Simply Wall St
10 Best Large Cap Stocks to Buy Under $20
10/23/2025 - Insider Monkey
3 Reasons to Sell VTRS and 1 Stock to Buy Instead
10/22/2025 - StockStory Articles
How Viatris is Fighting Infectious Disease
10/21/2025 - GuruFocus
Will Viatris (VTRS) Beat Estimates Again in Its Next Earnings Report?
10/21/2025 - Zacks Investment Research
How Viatris is Fighting Infectious Disease
10/21/2025 - ACCESS Newswire
Viatris Inc. (VTRS) Acquires Aculys Pharma, Inc
10/21/2025 - Yahoo! Finance: News
Viatris Inc. (VTRS) Acquires Aculys Pharma, Inc
10/21/2025 - Insider Monkey
General Motors, Nvidia, Viatris, BCE, Rocket Lab: Trending by Analysts
10/18/2025 - TipRanks Financial Blog
Teva Vs. Viatris: Who Will Dominate In President Trump's America?
10/17/2025 - Seeking Alpha - Long Ideas
Teva Vs. Viatris: Who Will Dominate In President Trump's America?
10/17/2025 - SeekingAlpha
Viatris (VTRS): Exploring Valuation After Recent Market Attention and Modest Share Price Gains
10/16/2025 - Simply Wall St
Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan
10/16/2025 - Zacks Investment Research
Viatris (VTRS) Expands Japanese Market Presence with Aculys Pharma Acquisition
10/15/2025 - GuruFocus
Viatris completes Aculys Pharma acquisition
10/15/2025 - SeekingAlpha.com: All News
Viatris completes Aculys Pharma acquisition
10/15/2025 - Seeking Alpha - Healthcare
Viatris (VTRS) Expands Neurology Portfolio with Aculys Pharma Acquisition
10/15/2025 - GuruFocus
Viatris completes acquisition of Aculys Pharma
10/15/2025 - TipRanks Financial Blog
Viatris completes acquisition of Aculys Pharma
10/15/2025 - The Fly
Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia in Japan and Certain Other Markets in the Asia-Pacific Region
10/15/2025 - PR Newswire
How Viatris Prevents and Manages NCDs
10/15/2025 - GuruFocus
How Viatris Prevents and Manages NCDs
10/15/2025 - ACCESS Newswire
Income Statement
Total Revenue (TTM)
$14.12B
EBITDA (TTM)
$4.09B
EBIT (TTM)
$1.51B
Net Income (TTM)
-$3.47B
Balance Sheet
Total Assets (Q)
$38.41B
Total Debt (Q)
$14.81B
Total Liabilities (Q)
$22.84B
Book Value Per Share (Q)
$13.36
Cash Flow
Cash from Operations (TTM)
$2.06B
Cash from Investing (TTM)
$1.46B
Cash from Financing (TTM)
-$3.89B
Net Change in Cash (TTM)
-$350.70M
Filings
Filing Date
Thursday, August 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Loading...
Beta
0.87
7-Day Total Return
3.07%
30-Day Total Return
8.44%
60-Day Total Return
19.50%
90-Day Total Return
20.04%
Year to Date Total Return
-12.94%
1-Year Total Return
-4.62%
2-Year Total Return
27.13%
3-Year Total Return
22.05%
5-Year Total Return
-16.35%
52-week Low
Apr 10, 2025 - $6.85
52-week High
Nov 25, 2024 - $13.55
Valuation
Market Cap
$12.07B - Large Cap
Enterprise Value
$26.07B
Price/Sales (TTM)
0.86
Price/Book (Q)
0.77
Dividends and Shares
Shares Outstanding
1.17K
Dividend Per Share (Most Recent)
$0.12
Dividend Per Share (TTM)
$0.48
Corporate Info
Website
www.viatris.com
Phone Number
724 514 1800
Address
Robert J. Coury Global Center
Canonsburg, PA 15317
Country
United States
Year Founded
1961
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin... more
NASDAQ 10/27/2025 3:39PM Eastern Quotes delayed